Shock Wave Therapy Plus Exercise in GTPS (GTPSSWEX)

January 31, 2024 updated by: Ettore Carlis, Foundation IRCCS San Matteo Hospital

Shock Wave Therapy Combined With Strengthening Exercise of Hip Abductor Muscles in the Greater Trochanteric Pain Syndrome: a Randomized Controlled Trial

The aim of this randomized controlled study is to investigate if the sequential administration of focused shock wave therapy and of a rehabilitation program based on the strengthening of gluteal muscles is more effective than a standard shock wave treatment for greater trochanteric pain syndrome

Study Overview

Study Type

Interventional

Enrollment (Estimated)

80

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Pavia, Italy, 27100
        • Fondazione IRCCS Policlinico San Matteo

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Unilateral hip pain of four weeks or longer duration
  • Pain to palpation in the greater trochanteric area at physical examination
  • Pain in hip end-range abduction/rotation/adduction at physical examination
  • Gluteal tendinopathy, in absence of full thickness tears at a sonographic examination of the gluteal tendons
  • Adult age and written informed consent

Exclusion Criteria:

  • No hip osteoarthritis, diagnosed according to Altman's criteria
  • No history of knee osteoarthritis
  • No history of rheumatologic diseases
  • No previous fractures or surgery in the affected limb
  • No clinical signs of lumbar radiculopathy at physical examination
  • No corticosteroid injections, since the onset of the current pain episode
  • No general contraindication to shock wave therapy (pregnancy, bleeding disorders or anticoagulant drug usage, cancer in the focal area)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: exercise plus shockwaves

Enrolled subject will be treated with focused shock wave therapy, once a week for three consecutive weeks, by a specialized physician, using a device powered by an electromagnetic generator.

Focusing: (out-of-line) ultrasound-guided with the patient lying in lateral decubitus.

Dosimetry: 1500-1800 shots per session with an energy flux density equal to 0.10-0.20 mJ/mm2 (frequency=4Hz).

The experimental group will then start a physiotherapy program for the following 8 weeks. The program is made up of strengthening and stretching exercises of gluteal muscles, planned to be daily performed at home. Four supervised physiotherapy session will be planned on week 0-1-2-4, during which the exercise loading will be implemented.

Physiotherapy program (8 weeks)
Focused shock wave therapy (3 weeks)
Active Comparator: shockwaves

Enrolled subject will be treated with focused shock wave therapy, once a week for three consecutive weeks, by a specialized physician, using a device powered by an electromagnetic generator.

Focusing: (out-of-line) ultrasound-guided with the patient lying in lateral decubitus.

Dosimetry: 1500-1800 shots per session with an energy flux density equal to 0.10-0.20 mJ/mm2 (frequency=4Hz).

Focused shock wave therapy (3 weeks)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
NRS Pain
Time Frame: 6 months
Change in lateral hip pain measured by the Numeric Rating Scale (NRS)
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
EQ5D Quality of life
Time Frame: 12 months
Change in quality of life measured by EQ-5D-3L
12 months
VISA-G Disability
Time Frame: 12 months
Change in disability measured by VISA-G questionnaire
12 months
Functional capacity (strength of gluteal muscles)
Time Frame: 12 months
Change in functional capacity measured by MRC scale
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 26, 2024

Primary Completion (Estimated)

July 1, 2026

Study Completion (Estimated)

February 1, 2027

Study Registration Dates

First Submitted

January 31, 2024

First Submitted That Met QC Criteria

January 31, 2024

First Posted (Actual)

February 8, 2024

Study Record Updates

Last Update Posted (Actual)

February 8, 2024

Last Update Submitted That Met QC Criteria

January 31, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 0005201/24

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Greater Trochanteric Pain Syndrome of Both Lower Limbs

Clinical Trials on Rehabilitation program based on the strengthening of gluteal muscles

3
Subscribe